fbpx

Aspercreme Lidocaine Patches Misleading Claims Illinois Complaint

May 1, 2021

The Food and Drug Administration (FDA) regulates the claims that drug companies are permitted to make for over-the-counter products. The complaint for this class action alleges that Sanofi US Corporation makes excessive claims on the packaging and labeling of its Aspercreme external analgesic patches, which use the active ingredient lidocaine at a concentration of 4%.

Case Event File: Aspercreme Lidocaine Patches Misleading Claims Illinois Complaint

Related to: Aspercreme Lidocaine Patches Misleading Claims Illinois Class Action